Provectus Biopharmaceuticals, Inc. announced it raised $200,000 in an initial filing from an offering of $5 Million
Provectus Biopharmaceuticals, Inc. announced it raised $200,000 in an initial filing from an offering of $5 Million
08/31/21, 11:35 AM
Location
knoxvilleMoney raised
$200,000
Industry
healthcare
Round Type
pre-seed
Company Info
Location
800 s. gay street
knoxville, tennessee, united states
Additional Info
Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus’ investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers.